Search For "covax"
After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will
Updated : 4 years, 8 months ago IST
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Healt
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Bangladesh receives first consignment of COVID-19 vaccine Moderna from US
Updated : 4 years, 8 months ago IST
Dhaka [Bangladesh], July 3 (ANI): Bangladesh received the first consignment of COVID-19 vaccine Moderna from the US on Friday through the COVAX initiative.
Read More
Congress says, why Centre 'conspicuously silent' on Covaxin pricing contro
Updated : 4 years, 8 months ago IST
New Delhi [India], July 3 (ANI): The Congress Party on Friday cornered the central government over the Covaxin pricing controversy in Brazil and asked the Centre why it is "conspicuously silent" on the matter.
Read More
Curtailed COVID-19 vaccination drive to resume at limited centres in Mumba
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 2 (ANI): Amid a shortage of COVID-19 vaccine doses in the state, the vaccination drive in Mumbai will resume for three hours at a limited number of its centres, the Brihanmumbai Municipal Corporation (BMC) said on Friday.
Read More
COVAX calls for equal recognition of COVID-19 vaccines
Updated : 4 years, 8 months ago IST
New York [US], July 2 (ANI): COVAX, the global alliance for vaccine distribution, on Thursday urged governments around the world to recognize as fully vaccinated all people who have received COVID-19 vaccines that have been deemed safe and effective by the World Health Organization (WHO).
Read More
Switzerland, Iceland, 7 EU nations okay SII's Covishield vaccine, day afte
Updated : 4 years, 8 months ago IST
Zurich [Switzerland], July 1 (ANI): A day after external affairs minister S Jaishankar said he has taken up with European Union to accept COVID-19 vaccines, such as Covishield and Covaxin, for Indian nationals travelling to Europe, Switzerland, Iceland and seven European Union countries on T
Read More
India offers reciprocal exemption of EU Digital COVID Certificate on incl
Updated : 4 years, 8 months ago IST
New Delhi [India], June 30 (ANI): India has requested EU member states to individually consider extending exemption to those persons who have taken Covishield and Covaxin and said it will institute a reciprocal policy for recognition of the EU Digital COVID Certificate, sources said.
Read More
COVID-19 in children often asymptomatic, 2pc-3 pc infected kids may requir
Updated : 4 years, 9 months ago IST
New Delhi [India], June 30 (ANI): COVID-19 in children is often asymptomatic and rarely require hospitalisation, however it is possible that a small percentage of children who get infected may need hospitalization and the Centre is making all adequate arrangements in terms of healthcare infr
Read More
Bharat Biotech to soon start Covaxin manufacturing facility in Bengaluru
Updated : 4 years, 9 months ago IST
New Delhi [India], June 30 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that the company hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon.
Read More
Covaxin booster dose trial results likely to come by November, say sources
Updated : 4 years, 9 months ago IST
New Delhi [India], June 30 (ANI): Results of trials of the third booster dose of Bharat Biotech's COVID-19 vaccine Covaxin is expected to come by November this year, sources told ANI.
Read More
Bharat Biotech denies receiving advance payments, supplying vaccines to Br
Updated : 4 years, 9 months ago IST
Hyderabad (Telangana) [India], June 30 (ANI): Issuing clarification on COVAXIN pricing controversy in Brazil, Bharat Biotech on Tuesday said it followed a step-by-step regulatory approval process during the eight-month period, but the company has neither received any advance payments nor
Read More